176 results on '"Mom, Constantijne H."'
Search Results
2. Diagnostic accuracy of MRI, CT, and [18F]FDG-PET-CT in detecting lymph node metastases in clinically early-stage cervical cancer — a nationwide Dutch cohort study
3. Improving histotyping precision: The impact of immunohistochemical algorithms on epithelial ovarian cancer classification
4. Lymphatic mapping for image-guided radiotherapy in patients with locally advanced uterine cervical cancer: a feasibility study
5. Phenotype-guided targeted therapy based on functional signal transduction pathway activity in recurrent ovarian cancer patients: The STAPOVER study protocol
6. Optimising follow-up strategy based on cytology and human papillomavirus after fertility-sparing surgery for early stage cervical cancer: a nationwide, population-based, retrospective cohort study
7. Risk of venous thromboembolism and bleeding after major surgery for ovarian cancer: standard in-hospital versus extended duration of thromboprophylaxis
8. Treatment Strategies Guided by [18F]FDG-PET/CT in Patients with Locally Advanced Cervical Cancer and [18F]FDG-Positive Lymph Nodes
9. Survival of Women with Advanced Stage Cervical Cancer: Neo-Adjuvant Chemotherapy Followed by Radiotherapy and Hyperthermia versus Chemoradiotherapy
10. The role of lymph nodes in cervical cancer: incidence and identification of lymph node metastases—a literature review
11. Survival associated with extent of radical hysterectomy in early-stage cervical cancer: a subanalysis of the Surveillance in Cervical CANcer (SCCAN) collaborative study
12. Is less more in the surgical treatment of early-stage cervical cancer?
13. [18F]FDG-PET or PET/CT in the evaluation of pelvic and para-aortic lymph nodes in patients with locally advanced cervical cancer: A systematic review of the literature
14. Evaluating the effectiveness of pre-operative diagnosis of ovarian cancer using minimally invasive liquid biopsies by combining serum human epididymis protein 4 and cell-free DNA in patients with an ovarian mass.
15. Vulvar and vaginal neoplasia in women with inflammatory bowel disease
16. Sexual functioning more than 15 years after premenopausal risk-reducing salpingo-oophorectomy
17. Urinary incontinence more than 15 years after premenopausal risk‐reducing salpingo‐oophorectomy: a multicentre cross‐sectional study.
18. #1119 Survival associated with extent of radical hysterectomy in early-stage cervical cancer: a sub-analysis of the SCCAN collaborative study
19. #223 Recurrence-free survival of cervical adenocarcinoma in situ following lletz, conisation or hysterectomy
20. #814 Suspicious lymph nodes on PET-CT and the impact on nodal treatment in advanced cervical cancer
21. Methylation testing for the detection of recurrent cervical intraepithelial neoplasia
22. Urinary incontinence more than 15 years after premenopausal risk‐reducing salpingo‐oophorectomy: a multicentre cross‐sectional study
23. Non-invasive detection of endometrial cancer by DNA methylation analysis in urine
24. More attention is needed for the corrigendum to the revised FIGO staging for carcinoma of the cervix uteri
25. An analysis of deviation from the ESGO quality indicators for surgical treatment of cervical cancer in a large referral center in the Netherlands.
26. The risk of lymph node metastasis in the new FIGO 2018 stage IA cervical cancer with >7 mm diameter.
27. Figure S2 from Adenocarcinoma of the Uterine Cervix Shows Impaired Recruitment of cDC1 and CD8+ T Cells and Elevated β-Catenin Activation Compared with Squamous Cell Carcinoma
28. Supplementary Data from Mapatumumab, a Fully Human Agonistic Monoclonal Antibody That Targets TRAIL-R1, in Combination with Gemcitabine and Cisplatin: a Phase I Study
29. Table S1 from Adenocarcinoma of the Uterine Cervix Shows Impaired Recruitment of cDC1 and CD8+ T Cells and Elevated β-Catenin Activation Compared with Squamous Cell Carcinoma
30. Long‐term effects of premenopausal risk‐reducing salpingo‐oophorectomy on cognition in women with high familial risk of ovarian cancer: A cross‐sectional study
31. Risk of venous thromboembolism and bleeding after major surgery for ovarian cancer: standard in-hospital versus extended duration of thromboprophylaxis
32. Lymphatic mapping for image-guided radiotherapy in patients with locally advanced uterine cervical cancer:a feasibility study
33. Association of Hospital Surgical Volume With Survival in Early-Stage Cervical Cancer Treated With Radical Hysterectomy
34. Effect of HIPEC according to HRD/BRCAwt genomic profile in stage III ovarian cancer: Results from the phase III OVHIPEC trial
35. Analysis of isolated loco-regional recurrence rate in intermediate risk early cervical cancer after a type C2 radical hysterectomy without adjuvant radiotherapy
36. Psychological impact of referral to an oncology hospital on patients with an ovarian mass
37. Association of Hospital Surgical Volume With Survival in Early-Stage Cervical Cancer Treated With Radical Hysterectomy
38. 2022-RA-1301-ESGO The impact of hospital surgical volume on survival in early-stage cervical cancer treated with radical hysterectomy: a sub-analysis of the SCCAN study
39. 2022-RA-1174-ESGO Role of adjuvant therapy in intermediate-risk cervical cancer patients – SCCAN study sub-analysis
40. 2022-RA-1471-ESGO Radical hysterectomy is not superior to chemoradiation in early stage cervical cancer with suspicious lymph nodes: a propensity score analysis
41. Establishment of the Dutch nationwide, interdisciplinary infrastructure and biobank for fundamental and translational ovarian cancer research: Archipelago of Ovarian Cancer Research (AOCR)
42. Implementation of laparoscopic hysterectomy for endometrial cancer over the past decade
43. Effect of HIPEC according to HRD /BRCA wtgenomic profile in stage III ovarian cancer: Results from the phase III OVHIPEC trial
44. Immunotherapeutic Approaches for the Treatment of HPV-Associated (Pre-)Cancer of the Cervix, Vulva and Penis
45. Psychological impact of referral to an oncology hospital on patients with an ovarian mass.
46. HPV and DNA Methylation Testing in Urine for Cervical Intraepithelial Neoplasia and Cervical Cancer Detection
47. The prognostic value of the number of positive lymph nodes and the lymph node ratio in early‐stage cervical cancer
48. Post-recurrence survival in patients with cervical cancer
49. Primary or adjuvant chemoradiotherapy for cervical cancer with intraoperative lymph node metastasis – A review
50. The annual recurrence risk model for tailored surveillance strategy in patients with cervical cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.